Hypouricemic effect and safety of febuxostat used for prevention of tumor lysis syndrome

PURPOSE: We evaluated the efficacy and safety of febuxostat, a non-purine xanthine oxidase inhibitor, used for prevention of hyperuricemia associated with tumor lysis syndrome (TLS). METHODS: Records of adult patients with newly diagnosed or relapsed hematologic malignancies who received febuxostat...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Maie, Koichiro, Yokoyama, Yasuhisa, Kurita, Naoki, Minohara, Hideto, Yanagimoto, Shintaro, Hasegawa, Yuichi, Homma, Masato, Chiba, Shigeru
格式: Artigo
語言:Inglês
出版: Springer International Publishing 2014
主題:
Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4164671/
https://ncbi.nlm.nih.gov/pubmed/25279293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2193-1801-3-501
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍